Cargando…

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China

The BCG vaccine is prepared from a weakened strain of Mycobacterium bovis (M. bovis), a bacterium closely related to Mycobacterium tuberculosis (MTB), which causes tuberculosis (TB). The vaccine was developed over 13 years, from 1908 to 1921, in the French Institut Pasteur by Léon Charles Albert Cal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junli, Lu, Jinbiao, Wang, Guozhi, Zhao, Aihua, Xu, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320669/ https://www.ncbi.nlm.nih.gov/pubmed/35891320 http://dx.doi.org/10.3390/vaccines10071157

Ejemplares similares

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Li, Junli, et al.
Publicado: (2021)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
por: Monteiro-Maia, Renata, et al.
Publicado: (2014)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
por: Sisco, Maria Carolina, et al.
Publicado: (2020)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
por: Chavarri-Guerra, Yanin, et al.
Publicado: (2019)

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
por: Khanum, Iffat, et al.
Publicado: (2021)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
por: Al Waili, Badria, et al.
Publicado: (2021)

Unmethylated CpG motif-containing genomic DNA fragment of Bacillus calmette-guerin promotes macrophage functions through TLR9-mediated activation of NF-κB and MAPKs signaling pathways
por: Li, Junli, et al.
Publicado: (2019)

Positive impact of rescheduling Bacillus Calmette-Guérin vaccination on vaccinations at birth
por: Oberoi, Simmi, et al.
Publicado: (2017)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
por: Palmer, Mitchell V., et al.
Publicado: (2018)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

Generalized Granuloma Annulare in Infancy Following Bacillus Calmette-Guerin Vaccination
por: Lee, Sang Woo, et al.
Publicado: (2011)

Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination
por: Shoaran, Maryam, et al.
Publicado: (2013)

Effectiveness of bacillus Calmette–Guerin vaccination history on pulmonary tuberculosis symptoms
por: Farajnia, Safar, et al.
Publicado: (2019)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
por: Ylösmäki, Erkko, et al.
Publicado: (2021)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020)

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

Dual Bacillus Calmette–Guerin vaccination along the border communities of Angola and Namibia
por: Umar, Abubakar Sadiq, et al.
Publicado: (2016)

Adverse Reactions Due to the Bacillus Calmette-Guerin Vaccine: Twenty Tunisian Cases
por: Sellami, Khadija, et al.
Publicado: (2018)

Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns
por: Birk, Nina Marie, et al.
Publicado: (2017)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
por: Pasco, Samuel T., et al.
Publicado: (2020)

Does the Bacillus Calmette–Guérin vaccine provide protection from COVID-19?
por: Roy, Soumya
Publicado: (2020)

DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE
por: Diniz, Lilian Martins Oliveira, et al.
Publicado: (2020)

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
por: Kobayashi, Sayori, et al.
Publicado: (2021)

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
por: Taks, Esther J.M., et al.
Publicado: (2023)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
por: Lee, Chae Hun, et al.
Publicado: (2023)

Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes
Publicado: (1993)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
por: Al-Hammadi, Suleiman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ma85ugg95ptcf8p5ghv47cbalm